500 families join quest to unlock genetic secrets of miscarriage

NCT ID NCT05444283

Recruiting now Knowledge-focused Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to discover the genetic reasons behind recurrent pregnancy loss (RPL) by analyzing DNA from parents and pregnancy tissue. Researchers at Yale University will enroll 500 women who have had multiple pregnancy losses. The goal is to identify genetic markers that predict RPL, which could lead to better diagnosis and counseling in the future.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT PREGNANCY LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pregnancy loss, recurrent, 4 pregnancy loss, recurrent, susceptibility

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RECURRENT PREGNANCY LOSS

Contacts and locations

Locations

Columbia University
RECRUITING

New York, New York, 10032, United States
Johns Hopkins University
RECRUITING

Baltimore, Maryland, 21205, United States
Northwestern University
RECRUITING

Chicago, Illinois, 60611, United States
Pennsylvania State University
RECRUITING

Hershey, Pennsylvania, 17033, United States
University of Chicago
ACTIVE_NOT_RECRUITING

Chicago, Illinois, 60611, United States
University of Colorado
RECRUITING

Aurora, Colorado, 80045, United States
University of Texas at Austin
RECRUITING

Austin, Texas, 78712, United States
University of Texas at San Antonio
RECRUITING

San Antonio, Texas, 78299, United States
Wayne State University
RECRUITING

Detroit, Michigan, 48201, United States
Yale University
RECRUITING

New Haven, Connecticut, 06511, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.